focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Announcement of Appointments

11 Mar 2009 09:49

RNS Number : 6731O
Phorm Inc
11 March 2009
 



Phorm, Inc. ("Phorm" or the "Company")

Announcement of Appointments 

 

Phorm (AIM: PHRM and PHRX), the online advertising technology company, is pleased to announce the appointments of Sarah Simon as Financial and Strategic Development Officer and Mike Moore as Global Commercial Director. 

Sarah will have responsibility for the management of investor, analyst and shareholder relationships and financial communications. She will also provide analysis, research and strategic guidance to the business on all financial issues. Sarah reports to Phorm's CEO, Kent Ertugrul.

Sarah joins from Morgan Stanley where she spent 15 years and was a Managing Director in European Equity Research. She started her career in corporate finance, working on mergers and acquisitions, IPOs and restructuring then moved to equity research where she spent 12 years specialising in coverage of the European Media and Internet market. 

Mike will join Phorm on April and will be responsible for managing the fast-growing commercial opportunities for Phorm's technology as it is deployed globally. This will include overseeing partnership arrangements with advertisers and publishers to ensure the optimal performance of ad campaigns served through the Open Internet Exchange (OIX) Mike will report to Phorm's deputy CEO, Nan Richards.

Mike joins from the Telegraph Media Group (TMG) where he held the role of General Manager - Digital with overall P&L responsibility for Digital Operations and Marketing. While with TMG, Mike authored and executed its digital monetisation and publishing strategy, the implementation of which helped significantly boost the global audience of Telegraph.co.uk from 9 to 22 million unique users, making it one of the most visited UK newspaper sites worldwide. 

Prior to TMG, Mike held high level sales, interactive marketing and commercial development roles at AOL Europe and America Online.

Kent Ertugrul, CEO of Phorm, commented: "Sarah and Mike have in depth experience of the Internet industry that is highly relevant to Phorm. Sarah has a distinguished track record of analysis and communication on media and internet stocks within the financial sector. Meanwhile Mike has the necessary relevant expertise in delivering successful digital media strategies. Their appointments will significantly strengthen our capabilities, both in terms of driving our business strategy and fully developing the commercial opportunities that flow from our innovative technology."

End

For Phorm Enquiries:

David Sawday - Communications Director 

Maria Greenwood - Press Officer 

Tel: 0207 297 2537

About Phorm: 

Phorm is an innovative advertising technology company specialising in precision targeted advertising which preserves users' personal privacy and security. Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Ad Networks and Advertisers.

 

Phorm is a Delaware, US incorporated company, with offices in New York and London. 

The Company was admitted to the AIM market of the London Stock Exchange in 2004 

and has over 100 employees.

 

For more information, please visit: www.phorm.com http://www.phorm.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRADGGMFLMNGLZG
Date   Source Headline
5th Jan 20107:00 amRNSTransfer of shares
17th Dec 200911:51 amRNSPurchase of Shares and Total Voting Rights
4th Nov 20092:18 pmRNSNotification of major interest in shares
2nd Nov 200912:42 pmRNSResult of AGM
6th Oct 20092:07 pmRNSNotice of AGM
2nd Oct 20097:00 amRNSNotification of major interest in shares
21st Sep 20097:00 amRNSInterim results
14th Sep 20098:57 amRNSNotification of Results
5th Aug 20097:00 amRNSTransfer of Shares
8th Jul 20098:27 amRNSOperational Update
6th Jul 20099:22 amRNSStatement on UK operations
30th Jun 20097:13 amRNSAnnual Accounts
19th Jun 200911:06 amRNSTotal Voting Rights
18th Jun 20097:00 amRNSFinal Results
10th Jun 20097:00 amRNSPlacing to raise ?15 million
3rd Jun 200911:00 amRNSPhorm announces Webwise Discover
21st May 20097:00 amRNSKorean Market Trial
27th Apr 200910:31 amRNSStatement re Apology from "New Media Age" Magazine
14th Apr 20096:23 pmRNSPhorm Statement re EU Commission
9th Apr 20093:57 pmRNSAIM Block Admission
30th Mar 20097:00 amRNSKorean Market Trial
26th Mar 20097:03 amRNSGrant of Options
19th Mar 20091:31 pmRNSGrant of Options
18th Mar 20097:00 amRNSChange of Broker
13th Mar 20095:03 pmRNSShare Issue - Replacement
13th Mar 20092:46 pmRNSShare Issue
11th Mar 20099:49 amRNSAnnouncement of Appointments
4th Mar 20093:18 pmRNSCity Events Wire
17th Dec 20085:52 pmRNSManagement Appointments
15th Dec 20087:00 amRNSBT Trial Update
1st Dec 20087:00 amRNSPhorm Announces Board Changes
5th Nov 20087:46 amRNSDisclosure of Share Sale
22nd Oct 20085:14 pmRNSGrant of options
14th Oct 200810:15 amRNSCancellation of admission of shares
30th Sep 20087:00 amRNSInterim Results
29th Sep 20087:00 amRNSCommencement of BT Trial
22nd Sep 200811:15 amRNSResponse to Statement by BERR
4th Sep 20087:00 amRNSPhorm Update
18th Aug 20087:00 amRNSAppointment of Independent Bo
24th Jun 20087:00 amRNSTransfer of Shares
14th May 20084:45 pmRNSExercise of Options
14th May 200812:55 pmRNSAnnual Report and Accounts
10th Apr 20087:01 amRNSFinal Results
4th Apr 20084:23 pmRNSNotification of Holding
4th Apr 20084:16 pmRNSNotification Of Shareholding
4th Apr 200812:11 pmRNSNotification Of Shareholding
19th Mar 20087:01 amRNSIssue of Equity
13th Mar 200811:32 amRNSResult of Stockholder Meeting
11th Mar 20087:02 amRNSRe Share Price Movement
28th Feb 20085:50 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.